{
  "nct_id": "NCT87304415",
  "indication": "Parkinson's Disease",
  "phase": "Phase 3",
  "sample_size": 1164,
  "duration_weeks": 50,
  "dropout_rate": 0.22,
  "blinding": "double-blind",
  "control_arm": "placebo",
  "primary_endpoints": [
    "ON time without dyskinesia"
  ],
  "secondary_endpoints": [
    "UPDRS score improvement",
    "OFF time reduction"
  ],
  "outcome_summary": "No significant difference compared to placebo",
  "success": 0,
  "failure_reason": "High dropout rate affected statistical analysis",
  "start_date": "2022-05-27",
  "completion_date": "2023-05-12"
}